AVAI BIO, INC. Asset Acquisition Consideration Transferred Other Assets
AVAI BIO, INC. (AVAI) reported Asset Acquisition Consideration Transferred Other Assets of -$149.00 thousand for the 9-month period ending 2023-12-31, per its 10-Q filed 2024-02-14.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:AssetAcquisitionConsiderationTransferredOtherAssets · last filed 2024-02-14
- AVAI BIO, INC. asset acquisition consideration transferred other assets for the quarter ending 2023-12-31 was $0.00.
- AVAI BIO, INC. asset acquisition consideration transferred other assets for the quarter ending 2023-09-30 was -$298.00K.
- AVAI BIO, INC. asset acquisition consideration transferred other assets for the quarter ending 2023-06-30 was $149.00K.
| Period end | Asset Acquisition Consideration Transferred Other Assets 3 month | Asset Acquisition Consideration Transferred Other Assets 6 month | Asset Acquisition Consideration Transferred Other Assets 9 month |
|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-14 | -$298.00K derived: sum of 2 quarters · filed 2024-02-14 | -$149.00K 10-Q · filed 2024-02-14 |
| 2023-09-30 | -$298.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-17 | -$149.00K 10-Q · filed 2023-11-17 | |
| 2023-06-30 | $149.00K 10-Q · filed 2023-08-16 |